欣旺达：接受浙商证券等投资者调研

Group 1 - The company Xiwanda announced that on August 27, 2025, it will accept investor research from Zheshang Securities and others, with the company secretary and CFO participating in the discussions [1] - The discussions will address questions raised by investors regarding the company's operations and future prospects [1] Group 2 - The news highlights a significant advancement in the medical field with the world's first successful transplantation of gene-edited pig lungs into humans, raising questions about the timeline for clinical applications [1] - The article features an interview with key participants involved in this groundbreaking procedure, emphasizing the potential implications for future medical treatments [1]